SG Americas Securities LLC Purchases 35,823 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

SG Americas Securities LLC increased its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 65.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,355 shares of the company’s stock after purchasing an additional 35,823 shares during the period. SG Americas Securities LLC’s holdings in LifeStance Health Group were worth $666,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Point72 Asset Management L.P. purchased a new stake in shares of LifeStance Health Group in the second quarter worth approximately $4,326,000. Geode Capital Management LLC grew its holdings in LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after buying an additional 729,794 shares in the last quarter. Wellington Management Group LLP raised its position in LifeStance Health Group by 15.2% in the 3rd quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company’s stock valued at $33,813,000 after buying an additional 638,385 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in LifeStance Health Group by 82.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock valued at $4,991,000 after acquiring an additional 457,930 shares in the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in LifeStance Health Group during the 3rd quarter worth $3,150,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Price Performance

LFST opened at $8.12 on Friday. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The firm has a 50-day moving average of $7.58 and a 200 day moving average of $6.89. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market cap of $3.11 billion, a P/E ratio of -31.23 and a beta of 1.26.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.05. The firm had revenue of $312.70 million during the quarter, compared to the consensus estimate of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The company’s revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.17) EPS. On average, research analysts expect that LifeStance Health Group, Inc. will post -0.2 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Barclays increased their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a report on Monday, November 11th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.70.

Insiders Place Their Bets

In other news, Director Robert Bessler sold 75,000 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the completion of the transaction, the director now owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. This represents a 5.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 6.60% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.